Huagai Capital | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Huagai Capital/Activity

Huagai Capital Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Participated in QL Biopharma's 500M+ RMB (~$72.8M) Series C, led by OrbiMed, backing its metabolic-disease drug pipeline.

QL Biopharma

QL Biopharma Huagai Capital

flcube.comMAR 2, 2026

vcbeathealth.com

MAR 2, 2026

New Fund

Closed a new seed-stage healthcare fund at CNY 800M (~$125M), exceeding its CNY 500M target, to back early/mid-stage innovative drug and device projects.

Seed-stage healthcare fund (CNY 800M)

yicaiglobal.comJAN 10, 2022

JAN 10, 2022